Evidence map›Paper›PMID 40277045›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia.

Jesús Garcia Castro, Sara Rubio-Guerra, Kaitlin B Casaletto, Judit Selma González, Molly Memel, Lídia Vaqué-Alcázar, Alejandra Morcillo-Nieto, José Arriola-Infante, Oriol Dols-Icardo, Alexandre Bejanin and 20 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Exploring sex differences in bvFTD through clinician insights.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Sex differences in frontotemporal dementia.Nature reviews. Neurology · 2025
    Article
  4. Article
  5. Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Jesús Garcia CastroSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0003-1503-4775
Sara Rubio-GuerraSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Kaitlin B CasalettoWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Judit Selma GonzálezSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Molly MemelRay Dolby Brain Health Center, San Francisco, California, USA.
Lídia Vaqué-AlcázarSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alejandra Morcillo-NietoSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
José Arriola-InfanteSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Oriol Dols-IcardoSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alexandre BejaninSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Olivia BelbinSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Juan ForteaSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Daniel AlcoleaSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Maria Carmona-IraguiSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Isabel BarroetaSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Miguel Santos-SantosSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
María Belen Sánchez SaudinósSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Isabel Sala MataveraSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Hilary W HeuerWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Leah K ForsbergDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Kejal KantarciDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Adam M StaffaroniWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Carmela TartagliaTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Katherine P RankinWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Brad BoeveDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Adam BoxerWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Howard J RosenWeill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.
Alberto LleóSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ignacio Illán-GalaSant Pau Memory Unit, Department of Neurology, Biomedical Research Institute Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0002-5418-2052
ALLFTD Consortium

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI DANIEL H GESCHWIND · 2019 to 2026
$120.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
The Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1M
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)U01AG045390 · NIA · MAYO CLINIC ROCHESTER · PI BOEVE, BRADLEY F, ROSEN, HOWARD J · 2014 to 2018
$16.9M
The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Training - The Frontotemporal Lobar Degeneration Clinical Research ConsortiumU54NS092089 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2014 to 2018
$6.4M
DS-ARC: A Remote Digital Cognitive Assessment for Down Syndrome-Associated Alzheimer's DiseaseR01AG081394 · NIA · WASHINGTON UNIVERSITY · PI Jason J Hassenstab · 2023 to 2026
$6.0M
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Clinical trials to prevent Alzheimer's Disease in Down SyndromeR61AG066543 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAFII, MICHAEL S · 2019 to 2020
$5.6M
Unraveling the intersection of synaptic biology, lifestyle, and cognitive resilienceR01AG072475 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CASALETTO, KAITLIN B · 2021 to 2025
$4.3M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Multimodal Imaging in Frontotemporal DegenerationK24AG045333 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2013 to 2023
$1.9M
Alzheimer Association AARG-22-923680Alzheimer's Association AARF-22-924456Carlos III National Institute of Health of Spain CM21/00243Carlos III National Institute of Health of Spain CM23/00176Carlos III National Institute of Health of Spain CP20/00038Carlos III National Institute of Health of Spain INT21/00073Carlos III National Institute of Health of Spain JR20/0018Carlos III National Institute of Health of Spain PI18/00435Carlos III National Institute of Health of Spain PI20/01330Carlos III National Institute of Health of Spain PI20/01473Carlos III National Institute of Health of Spain PI21/00791Carlos III National Institute of Health of Spain PI21/01395Carlos III National Institute of Health of Spain PI22/00307Carlos III National Institute of Health of Spain PI23/01786Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas Program 1Department de Salut de la Generalitat de CatalunyaEuropean UnionEuropean Union. L.V.-A. UNI/551/2021Fondo Europeo de Desarrollo RegionalFundación Tatiana Pérez de Guzmán el Bueno IIBSP-DOW-2020-151Global Brain Health InstituteHorizon 2020-Research and Innovation Framework Programme from the European Union H2020-SC1-BHC-2018-2020Instituto de Salud Carlos III through the Río Hortega Fellowship CM21/00243″Jerome Lejeune Foundation postdoctoral fellowshipNational Institute of Neurological Diseases and StrokeNCATS NIH HHSNIA NIH HHS K24 AG045333NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG038791NIA NIH HHS R01 AG072475NIA NIH HHS R01 AG081394NIA NIH HHS R21 AG056974NIA NIH HHS R61 AG066543NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566NIA NIH HHS U01 AG045390NIA NIH HHS U19 AG063911NIH HHS AG032306NIH HHS AG038791NIH HHS K24AG045333NIH HHS R01 AG056850NIH HHS R01 AG061566NIH HHS R01AG072475NIH HHS R01 AG081394NIH HHS R21 AG056974NIH HHS R61AG066543NIH-NIANINDS NIH HHS U54 NS092089Pla Estratègic de Recerca I Innovació en Salut SLT002/16/00408Pla Estratègic de Recerca I Innovació en Salut SLT006/17/00119Una Manera de Hacer EuropaUnión Europea
6 · The paper itself

Abstract

introductionSelf-reported sex influences brain resilience, but its role in genetic frontotemporal dementia (FTD) remains unclear.

methodsWe analyzed 394 genetic-FTD patients and 279 controls from the ALLFTD consortium, assessing annual neuropsychological performance and MRI-based cortical thickness. Clinical characteristics and cortical thickness were compared between sexes. We used the residuals of linear regression models, which predict each participant's cognitive and behavioral performance levels relative to cortical thickness, as a proxy for reserve. We then modeled sex differences in longitudinal trajectories with linear mixed-effects models.

resultsSymptomatic females with genetic FTD had lower frontal cortical thickness than males, and the C9orf72 subgroup showed lower-than-expected frontal cortical thickness for a given level of executive functioning. Differences in cognitive reserve between sexes peaked near symptom onset but diminished thereafter. DISCUSSION: Females with genetic FTD showed higher cognitive reserve than males, suggesting that self-reported sex modulates resilience to frontotemporal neurodegeneration. HIGHLIGHTS: Females with genetic FTD showed higher cognitive reserve than males. Those differences were particularly pronounced in the C9orf72 and GRN subgroups. The higher cognitive reserve in females declined as the disease progressed.

Indexed as

Cognitive ReserveExecutive FunctionFrontotemporal DementiaSex CharacteristicsAgedBrain Cortical ThicknessC9orf72 ProteinFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsProgranulinsSex FactorsC9orf72 ProteinC9orf72 protein, humanProgranulinscognitive reservediagnosisfrontotemporal dementiamagnetic resonance imagingneuroimagingprogressionresiliencesurvival

Identifiers

PMID40277045
PMCPMC12022895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.